Expanding the p53 regulatory network: LncRNAs take up the challenge.

Long noncoding RNAs (lncRNAs) are rapidly emerging as important regulators of gene expression in a wide variety of physiological and pathological cellular processes. In particular, a number of studies revealed that some lncRNAs participate in the p53 pathway, the unquestioned protagonist of tumor suppressor response. Indeed, several lncRNAs are not only part of the large pool of genes coordinated by p53 transcription factor, but are also required by p53 to fine-tune its response and to fully accomplish its tumor suppressor program. In this review we will discuss the current and fast growing knowledge about the contribution of lncRNAs to the complexity of the p53 network, the different mechanisms by which they affect gene regulation in this context, and their involvement in cancer. The incipient impact of lncRNAs in the p53 biological response may encourage the development of therapies and diagnostic methods focused on these noncoding molecules. This article is part of a Special Issue entitled: Clues to long noncoding RNA taxonomy1, edited by Dr. Tetsuro Hirose and Dr. Shinichi Nakagawa.

[1]  E. Appella,et al.  Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.

[2]  Cole Trapnell,et al.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.

[3]  S. Dhanasekaran,et al.  The landscape of long noncoding RNAs in the human transcriptome , 2015, Nature Genetics.

[4]  Yu Fan,et al.  TGF-β–Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12 , 2014, Clinical Cancer Research.

[5]  D. Largaespada,et al.  PVT1 dependence in cancer with MYC copy-number increase , 2014, Nature.

[6]  J. Rinn,et al.  Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage , 2015, Nucleic acids research.

[7]  N. Caplen,et al.  p53-dependent Induction of PVT1 and miR-1204* , 2011, The Journal of Biological Chemistry.

[8]  Michael Q. Zhang,et al.  A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression , 2010, EMBO Journal.

[9]  C. Prives,et al.  Transcriptional regulation by p53. , 2010, Cold Spring Harbor perspectives in biology.

[10]  Zhaohui Feng,et al.  The Regulation of Aging and Longevity: A New and Complex Role of p53. , 2011, Genes & cancer.

[11]  M. Mhlanga,et al.  lncRNA and gene looping , 2014, Transcription.

[12]  K. Meletis,et al.  p53 suppresses the self-renewal of adult neural stem cells , 2005, Development.

[13]  J. Rinn,et al.  lincRNAs act in the circuitry controlling pluripotency and differentiation , 2011, Nature.

[14]  D. Bartel,et al.  lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.

[15]  Howard Y. Chang,et al.  Extensive and coordinated transcription of noncoding RNAs within cell cycle promoters , 2011, Nature Genetics.

[16]  M. Groudine,et al.  Functional and Mechanistic Diversity of Distal Transcription Enhancers , 2011, Cell.

[17]  C. Ponting,et al.  Intergenic lncRNAs and the evolution of gene expression. , 2014, Current opinion in genetics & development.

[18]  R. Kong,et al.  Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2 , 2015, Cell Death and Disease.

[19]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[20]  Runsheng Chen,et al.  Functional Characterization of Long Noncoding RNA Lnc_bc060912 in Human Lung Carcinoma Cells. , 2015, Biochemistry.

[21]  Fangting Wu,et al.  LncRNA loc285194 is a p53-regulated tumor suppressor , 2013, Nucleic acids research.

[22]  A. Hochberg,et al.  H19 expression in hepatic metastases from a range of human carcinomas , 2005, Journal of Clinical Pathology.

[23]  A. Hochberg,et al.  The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma , 2000, Molecular pathology : MP.

[24]  S. Nimer,et al.  The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior , 2009, Cell cycle.

[25]  R. Tjian,et al.  p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. , 1995, Science.

[26]  Alberto Inga,et al.  The expanding universe of p53 targets , 2009, Nature Reviews Cancer.

[27]  R. Elkon,et al.  eRNAs are required for p53-dependent enhancer activity and gene transcription. , 2013, Molecular cell.

[28]  Maite Huarte,et al.  Long non-coding RNAs and chromatin modifiers , 2014, Epigenetics.

[29]  K. Sakaguchi,et al.  Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.

[30]  Paulo P. Amaral,et al.  Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. , 2008, Genome research.

[31]  C. Méndez-Vidal,et al.  Wrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage. , 2016, Molecular cell.

[32]  S. Lottin,et al.  H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. , 1998, The American journal of pathology.

[33]  Lin Xu,et al.  Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma , 2015, Tumor Biology.

[34]  Feng Yang,et al.  Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells , 2012, The FEBS journal.

[35]  Kotb Abdelmohsen,et al.  LincRNA-p21 suppresses target mRNA translation. , 2012, Molecular cell.

[36]  S. Lottin,et al.  The human H19 gene is frequently overexpressed in myometrium and stroma during pathological endometrial proliferative events. , 2005, European journal of cancer.

[37]  D. Reinberg,et al.  CTCF regulates the human p53 gene through direct interaction with its natural antisense transcript, Wrap53 , 2014, Genes & development.

[38]  Karen H. Vousden,et al.  The ins and outs of p53 , 2000, Nature Cell Biology.

[39]  Jinsong Yang,et al.  Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma , 2014, Journal of Translational Medicine.

[40]  J. Zhao,et al.  Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma , 2015, Journal of Molecular Neuroscience.

[41]  H. Hermeking,et al.  MicroRNAs in the p53 network: micromanagement of tumour suppression , 2012, Nature Reviews Cancer.

[42]  Yiran Huang,et al.  Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. , 2013, Molecular bioSystems.

[43]  G. Tseng,et al.  Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas , 2006, Hepatology.

[44]  U. Gezer,et al.  Investigation of circulating lncRNAs in B-cell neoplasms. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[45]  Jonathan R. Hall,et al.  Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes , 2015, Cell Death and Disease.

[46]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[47]  Qiang Zhang,et al.  Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[48]  V. Villegas,et al.  Neighboring Gene Regulation by Antisense Long Non-Coding RNAs , 2015, International journal of molecular sciences.

[49]  Wilfried Haerty,et al.  Considerations when investigating lncRNA function in vivo , 2014, eLife.

[50]  Tae-Kyung Kim,et al.  Emerging epigenetic mechanisms of long non-coding RNAs , 2014, Neuroscience.

[51]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.

[52]  G. Pavesi,et al.  A perspective of promoter architecture from the CCAAT box , 2009, Cell cycle.

[53]  C. Kay,et al.  p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. , 2006, Reproductive biomedicine online.

[54]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[55]  J. Rinn,et al.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.

[56]  D. Danila,et al.  A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. , 2003, The Journal of clinical endocrinology and metabolism.

[57]  J. Hou,et al.  Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer , 2014, Oncotarget.

[58]  L. Bernd,et al.  Prognostic significance of drug-regulated genes in high-grade osteosarcoma , 2007, Modern Pathology.

[59]  Lin Zhao,et al.  LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis , 2014, Cell Death and Disease.

[60]  R. Grover,et al.  Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms , 2008, Cell cycle.

[61]  Y. Mo,et al.  The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage , 2012, Cell Research.

[62]  Reuven Agami,et al.  Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA , 2015, Nature Communications.

[63]  J. Rinn,et al.  A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response , 2010, Cell.

[64]  H. Tse,et al.  The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters , 2014, Cell Research.

[65]  J. Rinn,et al.  Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2 , 2013, Genome Biology.

[66]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[67]  Leighton J. Core,et al.  Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters , 2008, Science.

[68]  C. Sensen,et al.  LincRNA-p21 acts as a mediator of ING1b-induced apoptosis , 2015, Cell Death and Disease.

[69]  H. Hermeking,et al.  Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.

[70]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[71]  E. White,et al.  Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.

[72]  Xiaoping Zhou,et al.  Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. , 2014, Gynecologic oncology.

[73]  M. Noguchi,et al.  Phenotypic characterization of endometrial stromal sarcoma of the uterus , 2006, Cancer science.

[74]  G. Natoli,et al.  Noncoding transcription at enhancers: general principles and functional models. , 2012, Annual review of genetics.

[75]  O. Fodstad,et al.  Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. , 2013, Clinical colorectal cancer.

[76]  P. Pineau,et al.  Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit , 2014, Nature Communications.

[77]  Katsuki Ito,et al.  Loss of H19 imprinting in esophageal cancer. , 1996, Cancer research.

[78]  ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. , 2011, Cell.

[79]  Yuechao Ding,et al.  Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma. , 2014, International journal of clinical and experimental pathology.

[80]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[81]  Elke Hacker,et al.  Melanoma cell invasiveness is regulated by miR‐211 suppression of the BRN2 transcription factor , 2011, Pigment cell & melanoma research.

[82]  C. Prives,et al.  Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.

[83]  Hiromu Suzuki,et al.  Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites. , 2014, Human molecular genetics.

[84]  L. Marchionni,et al.  hGTSE-1 Expression Stimulates Cytoplasmic Localization of p53* , 2004, Journal of Biological Chemistry.

[85]  Benjamin G. Bitler,et al.  NF-YA Underlies EZH2 Upregulation and Is Essential for Proliferation of Human Epithelial Ovarian Cancer Cells , 2013, Molecular Cancer Research.

[86]  Yangchao Chen,et al.  Targeting long non-coding RNAs in cancers: progress and prospects. , 2013, The international journal of biochemistry & cell biology.

[87]  L. Diatchenko,et al.  Correlation of transcription of MALAT-1, a novel noncoding RNA, with deregulated expression of tumor suppressor p53 in small DNA tumor virus models. , 2013, Journal of cancer therapy.

[88]  T. Johnson,et al.  Reduced expression of the Caenorhabditis elegans p53 ortholog cep-1 results in increased longevity. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[89]  Min-hui Yang,et al.  MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. , 2011, International journal of oncology.

[90]  Emily A. Vucic,et al.  Human Cancer Long Non-Coding RNA Transcriptomes , 2011, PloS one.

[91]  Y. Jiao,et al.  Long intergenic non-coding RNA induced by X-ray irradiation regulates DNA damage response signaling in the human bronchial epithelial BEAS-2B cell line , 2014, Oncology letters.

[92]  Christopher J. Lee,et al.  A transcriptional sketch of a primary human breast cancer by 454 deep sequencing , 2009, BMC Genomics.

[93]  P. Sharp,et al.  LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint. , 2014, Molecular cell.

[94]  R. Kong,et al.  P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression , 2014, Cell Death and Disease.

[95]  Maite Huarte,et al.  Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature , 2014, Nature Communications.

[96]  Yunli Zhou,et al.  MEG3 noncoding RNA: a tumor suppressor. , 2012, Journal of molecular endocrinology.

[97]  Zhiming Cai,et al.  Long intergenic non‐coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder , 2013, Journal of surgical oncology.

[98]  C. Prives,et al.  Why Is p53 Acetylated? , 2001, Cell.

[99]  C. Cepko,et al.  The Noncoding RNA Taurine Upregulated Gene 1 Is Required for Differentiation of the Murine Retina , 2005, Current Biology.

[100]  Jing Zhao,et al.  Activation of p53 by MEG3 Non-coding RNA* , 2007, Journal of Biological Chemistry.

[101]  Maite Huarte,et al.  Long non-coding RNAs: challenges for diagnosis and therapies. , 2013, Nucleic acid therapeutics.

[102]  C. Prives,et al.  Getting p53 Out of the Nucleus , 2001, Science.

[103]  F. Recillas-Targa,et al.  Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines , 2010, Oncogene.

[104]  H. Ashktorab,et al.  MicroRNA-211 Expression Promotes Colorectal Cancer Cell Growth In Vitro and In Vivo by Targeting Tumor Suppressor CHD5 , 2012, PloS one.

[105]  P. Wei,et al.  Low expression of LOC285194 is associated with poor prognosis in colorectal cancer , 2013, Journal of Translational Medicine.

[106]  G. Macino,et al.  PVT1: A Rising Star among Oncogenic Long Noncoding RNAs , 2015, BioMed research international.

[107]  M. Gorospe,et al.  Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB , 2013, PLoS genetics.

[108]  G. Dranitsaris,et al.  CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. , 2010, Leukemia research.

[109]  Z. Zeng,et al.  LOC401317, a p53-Regulated Long Non-Coding RNA, Inhibits Cell Proliferation and Induces Apoptosis in the Nasopharyngeal Carcinoma Cell Line HNE2 , 2014, PloS one.

[110]  Wei Gu,et al.  SnapShot: p53 Posttranslational Modifications , 2008, Cell.

[111]  M. Mhlanga,et al.  lncRNA and gene looping: what's the connection? , 2014, Transcription.

[112]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[113]  Ci Zhao,et al.  LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway. , 2014, Oncology reports.

[114]  M. Halaby,et al.  The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage , 2006, Oncogene.

[115]  A. Hochberg,et al.  Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. , 1998, Molecular pathology : MP.

[116]  D. Levens,et al.  Isolation and Characterization of a Novel H1.2 Complex That Acts as a Repressor of p53-mediated Transcription* , 2008, Journal of Biological Chemistry.

[117]  J. Rinn,et al.  Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells , 2010, Nature Genetics.

[118]  Rui Xia,et al.  Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16 , 2015, Molecular Cancer.

[119]  Wen-Lin Kuo,et al.  Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer , 2007, Clinical Cancer Research.

[120]  Michael F. Lin,et al.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals , 2009, Nature.

[121]  S. Batalov,et al.  Antisense Transcription in the Mammalian Transcriptome , 2005, Science.

[122]  A. Levine,et al.  p53 regulates maternal reproduction through LIF , 2007, Nature.

[123]  Junhua Zheng,et al.  Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma , 2015, Tumor Biology.

[124]  David Malkin,et al.  Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. , 2010, Cancer research.

[125]  Kotb Abdelmohsen,et al.  Posttranscriptional gene regulation by long noncoding RNA. , 2013, Journal of molecular biology.

[126]  A. Fatica,et al.  Long non-coding RNAs: new players in cell differentiation and development , 2013, Nature Reviews Genetics.

[127]  Zigang Dong,et al.  Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.